Result of EGM and Warrantholder GM

    RNS Number : 0817J
  York Pharma plc
  27 November 2008
   


    York Pharma plc
    (the "Company")

    Result of EGM and Warrantholder GM

    London, UK, 27 November 2008 - York Pharma plc (AIM:YRK), the pharmaceutical company focused on the field of dermatology, announces that
all of the resolutions proposed at the Company's EGM, held at 11.00 a.m. this morning, were duly passed. Furthermore, the resolution
proposed at the Company's Warrantholder General Meeting held at 11.30 a.m. this morning was also duly passed.

    Further to the announcement of 28 October 2008 that the Company had conditionally placed 3,541,140 ordinary shares to raise �510,000,
dealings in 3,541,140 new ordinary shares in the Company are expected to commence on AIM on 28 November 2008. 

    - END -

    For further information please contact: 

    York Pharma plc

    Sue J Keast
    Company Secretary
    e-mail: s.keast@yorkpharma.com


    Collins Stewart Europe Limited

 Hugh Field/Adam Cowen  +44 (0)20 7523 8350



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
REGEAAFXAESPFFE

York Pharma (LSE:YRK)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024